Market closed
Chemed/$CHE
13:30
09:10
04:45
00:25
20:00
1D1W1MYTD1Y5YMAX
About Chemed
Chemed Corp operates subsidiaries in two main segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue. It provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The vast majority of the segment's revenue is received from the Medicare and Medicaid reimbursement programs. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers. Chemed generates the majority of its revenue from business in the United States.
Ticker
$CHE
Sector
Trading on
NYSE
Industry
Health Care Providers & Services
Headquarters
Employees
15,695
Website
Chemed Metrics
BasicAdvanced
$9B
30.90
$19.89
0.43
$1.90
0.33%
Price and volume
Market cap
$9B
Beta
0.43
52-week high
$639.61
52-week low
$512.12
Average daily volume
135K
Dividend rate
$1.90
Financial strength
Current ratio
1.382
Quick ratio
1.223
Long term debt to equity
8.806
Total debt to equity
12.587
Dividend payout ratio (TTM)
8.97%
Interest coverage (TTM)
209.14%
Management effectiveness
Return on assets (TTM)
13.95%
Return on equity (TTM)
27.12%
Valuation
Price to earnings (TTM)
30.904
Price to revenue (TTM)
3.798
Price to book
8
Price to tangible book (TTM)
25.42
Price to free cash flow (TTM)
25.097
Dividend yield (TTM)
0.31%
Forward dividend yield
0.33%
Growth
Revenue change (TTM)
7.37%
Earnings per share change (TTM)
10.93%
3-year revenue growth (CAGR)
4.36%
3-year earnings per share growth (CAGR)
5.68%
3-year dividend per share growth (CAGR)
4.89%
What the Analysts think about Chemed
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Chemed stock.
Chemed Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Chemed Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Chemed News
AllArticlesVideos
Chemed To Report First-Quarter 2025 Earnings April 23, Related Conference Call To Be Held On April 24
Business Wire·2 days ago
Chemed Corporation to Present at the Oppenheimer 35th Annual Healthcare Conference
Business Wire·1 month ago
Chemtrade Logistics Income Fund (CGIFF) Q4 2024 Earnings Call Transcript
Seeking Alpha·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Chemed stock?
Chemed (CHE) has a market cap of $9B as of April 03, 2025.
What is the P/E ratio for Chemed stock?
The price to earnings (P/E) ratio for Chemed (CHE) stock is 30.9 as of April 03, 2025.
Does Chemed stock pay dividends?
Yes, the Chemed (CHE) stock pays dividends to shareholders. As of April 03, 2025, the dividend rate is $1.9 and the yield is 0.33%. Chemed has a payout ratio of 8.97% on a trailing twelve-month basis.
When is the next Chemed dividend payment date?
The next Chemed (CHE) dividend payment date is unconfirmed.
What is the beta indicator for Chemed?
Chemed (CHE) has a beta rating of 0.43. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.